国际皮肤性病学杂志    2004 30 (5): 276-278   ISSN: 2096-5540  CN: 32-1880/R   米诺地尔治疗脱发的药理与临床研究 陈声利, 孙建方 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2004-01-06  修回日期 null  网络版发布日期 null 参考文献  [1] Boyera N,Galey I,Bernard BA.Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes.Skin Pharmacol,1997,10:206-220. [2] Baker CA,Uno H,Johnson GA.Minoxidil sulfation in the hair follicle.Skin Pharmacol,1994,7:335-339. [3] Meidan VM,Touitou E.Treatments for androgenetic alopecia and alopecia areata:current options and future prospects.Drugs,2001,61:53-69. [4] Yano K,Brown LF,Detmar M.Control of hair growth and follicle size by VEGF-mediated angiogenesis.J Clin Invest,2001,107:409. [5] KKhandpur S,Suman M,Reddy BS.Comparative efficacy of various treatment regimens for androgenetic alopecia in men.J Dermatol,2002,29:489-498. [6] KFiedler-Weiss VC,West DP,Buys CM,et al.Topical minoxidil doseresponse effect in alopecia areata.Arch Dermatol,1986,122:180. [7] Saraswat A,Kumar B.Minoxidil vs finasteride in the treatment of men with androgenet c alopecia.Arch De rmatol,2003,139:1219-1221. [8] 0lsen EA,Dunlap EE,Funicella T,et al.A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.J Am Acad Dermatol,2002,47:377-385. [9] Price VH,Menefee E,Strauss PC.Changes in hair weight and hair count in men with androgenetic alopecia,after application of 5% and 2% topical minoxidil,placebo,or no treatment.J Am Acad Dermatol,1999,41:717-721. [10] DeVillez RL,Jacobs JP,Szpunar CA,et al.Androgenetic alopecia in the female.Treatment with 2% topical minoxidil solution.Arch Dermatol,1994,130:303-307. [11] Price VH,Menefee E.Quantitative estimation of hair growth.I.androgenetic alopecia in women:effect of minoxidil.J Invest Dermatol,1990,95:683-687. [12] Fransway AF,Muller SA.3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.Cutis,1988,41:431-435. [13] Duvic M,Lemak NA,Valero V,et al.A randomized trial of minoxidil in chemotherapy-induced alopecia.J Am Acad Dermatol,1996,35:74-78. [14] Rodriguez R,Machiavelli M,Leone B,et al.Minoxidil(Mx) as a prophylaxis of doxorubicin-induced alopecia.Ann Oncol,1994,5:769-770. [15] Shapiro J.Safety of topical minoxidil solution:a one-year,prospective,observational study.J Cutan Med Surg,2003,7:322-329. [16] Dawber RP,Rundegren J.Hypertrichosis in females applying minoxidil topical solution and in normal controls.J Eur Acad Dermatol Venereol,2003,17:271-275. [17] Peluso AM,Misciali C,Vincenzi C,et al.Diffuse hypertrichosis during treatment with 5% topical minoxidil.Br J Dermatol,1997,136:118-120. [18] Friedman ES,Friedman PM,Cohen DE,et al.Allergic contact dermatitis to topical minoxidil solution:etiology and treatment.J Am Acad Dermatol,2002,46:309-312. [19] Trattner A,David M.Pigmented contact dermatitis from topical minoxidil 5%.Contact Dermatitis,2002,46:246. 通讯作者: